Synthesis of novel 1,2,4-oxadiazoles and analogues as potential anticancer agents

被引:98
作者
Kumar, Dalip [1 ]
Patel, Gautam [1 ]
Chavers, Angela K. [2 ,3 ]
Chang, Kuei-Hua [2 ,3 ]
Shah, Kavita [1 ,2 ,3 ]
机构
[1] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India
[2] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[3] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA
关键词
1,2,4-Oxadiazole; 1,3,4-Thiadiazole; Anticancer agents; RECEPTOR; DISCOVERY; SERIES; MECHANISM; SB-224289; AGONIST; DESIGN;
D O I
10.1016/j.ejmech.2011.03.031
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
A library of 3,5-disubstituted-1,2,4-oxadiazoles 7-9 and their bioisosters, 1,3,4-oxadiazole 14 and 1,3,4-thiadiazole 16, were synthesized and evaluated in vitro for their anticancer potential against a panel of six human cancer cell lines. The key step in the synthesis of oxadiazoles 7-9 involve coupling of amidoxime 6 with an appropriate carboxylic acid followed by thermal cyclization. The bioisosteres, 1,3,4-oxadiazole 14 and 1,3,4-thiadiazole 16 were prepared from the reaction of a common precursor diacylhydrazine 13 with thionyl chloride and Lawesson's reagent, respectively. The anticancer studies on the synthesized compounds revealed that presence of a cyclopentyloxy or n-butyloxy on the C-3 aryl ring and piperdin-4-yl or trichloromethyl at the C-5 position of 1,2,4-oxadiazole is essential for good activity. In particular, 1,2,4-oxadiazole 71 and analogue 1,3,4-thiadiazole 16 exhibited significant activity against DU145 (IC50: 9.3 mu M) and MDA-MB-231 (IC50: 9.2 mu M) cell lines, respectively. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:3085 / 3092
页数:8
相关论文
共 33 条
[1]
STEREOSPECIFIC TRANSDUCTION OF BEHAVIORAL-EFFECTS VIA DIAZEPAM-INSENSITIVE GABA(A) RECEPTORS [J].
ACRI, JB ;
WONG, G ;
WITKIN, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (03) :213-223
[2]
Armour D. R., 2000, PCT Int. Appl., Patent No. [WO2,000,039,125, 2000039125]
[3]
Ator NA, 1999, J PHARMACOL EXP THER, V289, P1434
[4]
Axel K., 2001, Pharmaceutical Substances: Syntheses, Patents, Applications
[5]
Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists [J].
Boys, ML ;
Schretzman, LA ;
Chandrakumar, NS ;
Tollefson, MB ;
Mohler, SB ;
Downs, VL ;
Penning, TD ;
Russell, MA ;
Wendt, JA ;
Chen, BB ;
Stenmark, HG ;
Wu, HW ;
Spangler, DP ;
Clare, M ;
Desai, BN ;
Khanna, IK ;
Nguyen, MN ;
Duffin, T ;
Engleman, VW ;
Finn, MB ;
Freeman, SK ;
Hanneke, ML ;
Keene, JL ;
Klover, JA ;
Nickols, GA ;
Nickols, MA ;
Steininger, CN ;
Westlin, M ;
Westlin, W ;
Yu, YX ;
Wang, YP ;
Dalton, CR ;
Norring, SA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) :839-844
[6]
Carlson RO, 2008, EXPERT OPIN INV DRUG, V17, P707, DOI [10.1517/13543784.17.5.707, 10.1517/13543784.17.5.707 ]
[7]
Novel 1,2,4-oxadiazoles as potent and selective histamine H-3 receptor antagonists [J].
Clitherow, JW ;
Beswick, P ;
Irving, WJ ;
Scopes, DIC ;
Barnes, JC ;
Clapham, J ;
Brown, JD ;
Evans, DJ ;
Hayes, AG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) :833-838
[8]
Process development of the PDE IV inhibitor 3-(cyclopentyloxy)-N-(3,5-dichloropyrid-4-yl)-4-methoxybenzamide [J].
Cook, DC ;
Jones, RH ;
Kabir, H ;
Lythgoe, DJ ;
McFarlane, IM ;
Pemberton, C ;
Thatcher, AA ;
Thompson, DM ;
Walton, JB .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1998, 2 (03) :157-168
[9]
Synthesis and cytotoxic profile of glycosyl-triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms [J].
dos Anjos, Janaina V. ;
Neves Filho, Ricardo A. W. ;
do Nascimento, Silene C. ;
Srivastava, Rajendra M. ;
de Melo, Sebastiao J. ;
Sinou, Denis .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (09) :3571-3576
[10]
Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist [J].
Feng, DQD ;
Biftu, T ;
Candelore, MR ;
Cascieri, MA ;
Colwell, LF ;
Deng, LP ;
Feeney, WP ;
Forrest, MJ ;
Hom, GJ ;
MacIntyre, DE ;
Miller, RR ;
Stearns, RA ;
Strader, CD ;
Tota, L ;
Wyvratt, MJ ;
Fisher, MH ;
Weber, AE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (13) :1427-1429